Characterization of a pH-sensitive surfactant, dodecyl-2-(1′-imidazolyl) propionate (DIP), and preliminary studies in liposome mediated gene transfer  by Liang, Earvin & Hughes, Jeffrey
ELSEVIER Biochimica et Biophysica Acta 1369 (1998) 39-50 
BIOCHIMICA ET BIOPHYSICA ACTA 
88N 
Characterization of a pH-sensitive surfactant, dodecyl-2-(l'-imidazolyl) 
propionate (DIP), and preliminary studies in liposome mediated 
gene transfer 
Earvin Liang, Jeffrey Hughes * 
Department ofPharmaceutics College of Pharmacy' University of Florida, P.O. Box 100494, Gainest,ille, FL 326 I0. USA 
Received 15 May 1997; accepted 7 July 1997 
Abstract 
The inefficiency of non-viral gene delivery systems, relative to viral systems, is likely due, in part, to the failure of 
endosomes to release DNA before reaching degradative lysosomes. A solution is to incorporate compounds in a delivery 
vector that will selectively increase the release of endosomally encapsulated DNA. To meet he above criteria, we designed, 
synthesized, and characterized the physicochemical and biological properties of such a compound, dodecyl-2-(l'-imidazolyl) 
propionate (DIP) to enhance cationic liposome mediated gene delivery. Several surface active techniques were used to 
characterize DIP lysing membranes. The critical micelle concentration f DIP was between 0.10-0.18 mM and the effective 
release and solubilization ratios were 1.0 and 4.0, respectively. DIP facilitated membrane disruption in both a pH and 
concentration dependent manner. In the presence of esterase at pH 7.0, the hydrolysis rate increased 32-fold indicating DIP 
can be degraded in the biological milieu. Toxicity of DIP by MTT assay in the SKnSH cell line demonstrated an IDs0 of 
1.2 raM, which is 30-fold higher than the concentration f DIP used to enhance gene transfection. When incorporated into 
cationic-liposomes, DIP enhanced transgene expression i vitro by 5-fold. The results of the study indicate that DIP may be 
a useful adjuvant to increase non-viral gene delivery to cells. © 1998 Elsevier Science B.V. 
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Abbreviations: BPS(s), biodegradable pH-sensitive 
surfactant(s); CMC, critical micelle concentration; CTAB, hexa- 
decyltrimethylammonium bromide; DIP, dodecyl 2-(l'-imidazo- 
lyl) propionate; DMPG, 1,2-dimyristoyl-sn-glycero-3-phos- 
phocholine; DOPE, dioleoylphosphatidyl ethanolamine; DOSPA, 
2,3 dioleyloxy-N-[(spermine carboxamino) ethyl]-N,N-dimethyl- 
1-propanaminium; DOTAP, dioleoyltrimethyl phosphatidyl phos- 
phate; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetra- 
zolium bromide; pDNA, plasmid DNA; R, molar ratio of 
DIP/total ipid; Re, effective release ratio; SDS, sodium dodecyl 
sulfate; Se, effective solubilization ratio 
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The therapeutic promise of using nucleic acids 
such as plasmid DNA (pDNA) and oligodeoxy- 
nuceotides as drugs is attractive. Several technical 
problems including stability and delivery must be 
overcome. An impediment to the therapeutic use of 
nucleic acids is their inefficient ransfer to the cyto- 
plasm and nucleus. 
A number of strategies have been employed to 
facilitate cell transfection with pDNA. The ideas 
behind these strategies are either to increase the 
amount of pDNA that associates with cells or to 
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increase the amount of nucleic acids that reach the 
cytoplasm by transiently disrupting endosomal mem- 
branes. The most common non-viral vectors used in 
gene delivery are cationic-liposomes [1]. In addition 
to protecting pDNA from enzymatic degradation [2], 
cationic-liposomes offer the potential to target genes 
via attached ligands. Other nucleic acid carriers in- 
clude cationic polymers such as poly-lysine [3] and 
polyamido starburst dendrimers [4]. Systems which 
have been shown to disrupt cellular membranes in- 
clude virosomes [5,6], pH-sensitive liposomes [7], 
viral peptides [8] and a-helical forming peptides 
[9,10]. However, each method has its disadvantages. 
pH-sensitive, anionic liposomes have low capacity to 
entrap pDNA since both have a negative charge. 
Cationic polymers and cationic-liposomes ventually 
become toxic to cells as their concentrations are 
increased more so than neutral counterparts. Fuso- 
genic peptides are expensive to produce and pose the 
problem of immunogenicity on repeat administration. 
Although nucleic acid uptake by cultured cells is 
inefficient [11], the use of cationic-liposomes has 
been shown to increase cellular nucleic acid delivery 
[12]. Evidence exists that pDNA/cationic-liposome 
complexes enter the cell via endocytosis in vitro [13] 
and initially accumulate in endosomes, with a major- 
ity of the pDNA later being degraded by enzymes 
within lysosomes. Because nucleic acids must first 
escape the endocytotic pathway to have an effect in 
the nucleus or cytoplasm, the endosomal membrane 
presents an additional barrier to an efficient delivery 
of nucleic acids to their subcellular targets. A manner 
to increase the amount of pDNA reaching the cyto- 
plasm is by increasing the amount escaping from the 
endocytotic pathway. 
The use of detergents to disrupt phospholipid bi- 
layers [14] is efficient, but most detergents are indis- 
criminate of membrane type and attack the first cellu- 
lar membrane they contact. One class of detergents 
which may offer some degree of site specific mem- 
brane disruption are the lysosomotropic detergents. 
This family of detergents was first described by 
Firestone et al. [15] and exhibited the ability to 
concentrate within intracellular acidic compartments 
and cause membrane rupture. Lysosomotropic deter- 
gents are particular lipophilic amines with p K, val- 
ues between 5 and 9, becoming protonated at acidic 
intralysosomal pH [15,16]. Upon protonation the sur- 
face activity of the lipophilic amine is enhanced 
leading to endosomal membrane destabilization. Early 
attempts at lysing late-stage ndosomes used pH-sen- 
sitive lysosomotropic detergents [17]. At neutral pH 
in the cytosol or intercellular fluid, a largely un- 
ionized lysosomotropic amine bearing a hydrocarbon 
chain has less surface active properties as compared 
to the ionized species. Upon ionization within an 
endosome due to a pH gradient, the surface active 
properties of the substance increase with its hy- 
drophobic tail buried in the hydrocarbon zone of the 
lipid bilayer and its hydrophillic protonated head 
group facing the aqueous interior of the lysosome. 
The surfactant then leads to the formation of mixed 
micelles within the endosomal membrane. Although 
later abandoned ue to problems with nonspecific 
lysosomal cellular destruction, the theory behind this 
approach as provided the basis for the development 
of biodegradable pH-sensitive surfactants (BPSs). 
BPSs are similar to the originally described lysoso- 
motropic detergents in that they become ionized at 
acidic pH. However, the novelty of the BPS delivery 
system stems from the biodegradability of the surfac- 
tant and the exploitation of a naturally occurring 
transport mechanism with a pH gradient. By develop- 
ing BPSs which can be protonated at the endosome 
(early lysosome) stage, they may be able to disrupt 
these endosomal membranes and liberate endosomal 
contents such as pDNA. Unlike the first described 
lysosomotropic detergents, BPSs can be easily de- 
graded because of the introduction cleavable connec- 
tor within the structure. Depending on the chemical 
characteristics of the connector, metabolism can oc- 
cur by a variety of mechanisms. 
In this report, we have characterized one member 
of the BPS family, dodecyl 2-(1-imidazolyl) propi- 
onate (DIP), by measuring its surface active proper- 
ties, cellular toxicity and stability. Using a model 
tissue culture system, we also investigated the use of 
DIP to enhance cationic-liposome mediated gene de- 
livery. 
2. Material and methods 
2.1. Preparation of reagents 
Calcein, rhodamine-6-G, ferric chloride and am- 
monium thiocyanate were purchased from Aldrich 
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(Milwaukee, WI). L-a-lecithin, dioleoylphosphatidyl 
ethanolamine (DOPE), dioleoyltrimethyl phos- 
phatidyl phosphate (DOTAP) and 1,2-dimyristoyl- 
sn-glycero-3-phosphocholine (DMPG) were pur- 
chased from Avanti Polar Lipids (Alabaster, AL). 
Porcine esterase (300U/mg protein) and cholesterol 
were purchased from Sigma (St. Louis, MO). 3-(4,5- 
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bro- 
mide (MTT) was purchased from Amresco (Solon, 
OH). The SKnSH (HTB-11) cell line was purchased 
from ATCC (Rockville, MD). 
DIP was synthesized as previously reported [18], 
purified through flash chromatography and its struc- 
ture confirmed through ~H-NMR, mass spectroscopy 
and elemental nalysis. Ammonium ferrothiocyanate 
(0.1 M) was prepared by dissolving 8.1 g ferric chlo- 
ride and 15.2g ammonium thiocyanate in 500ml of 
distilled water. 
All pH buffers were adjusted with NaC1 to 0.5 
ionic strength. The pH of the buffers (and their 
chemical compositions) used were as follows: pH 1.4 
(420mM KC1 and 80mM HC1), pH 2.8 (123mM 
citric acid and 60mM NaOH), pH 3.0 (120mM citric 
acid and 60mM NaOH), pH 4.3 (150mM sodium 
acetate and 350mM glacial acetic acid), pH 5.0 
(300mM KH2PO 4 and 50mM Na2HPO4), pH 5.5 
(300raM KH2PO 4 and 56mM Na2HPO4), pH 6.0 
(150~ KH2PO 4 and 100mM Na2HPO4), pH 6.5 
(240mM KH2PO 4 and 56mM Na2HPO4), pH 7.0 
(80mM KH2PO 4 and 120mM Na2HPO4), pH 7.5 
(70mlM KH2PO 4 and 150mM Na2HPO4) and pH 
8.0 (200mM KH2PO 4 and 188mM NaOH). 
Liposomes (L-a-lecithin: DMPG: cholesterol; 
weight ratio 5:1:4) were used as a model membrane 
system. In this case, the reverse-phase evaporation 
vesicle method [19] was used to produce unilamellar 
vesicles. Liposomes (600nm) were produced with 
polycarbonate membranes (Poretics; Livermore, CA) 
through a high pressure xtruder (Lipex Biomem- 
brane; Vancouver, Canada). Calcein (100mM) was 
entrapped within the liposomes as a fluorescent 
marker to monitor membrane lysis events. 
The concentration f phospholipid in each experi- 
ment was measured by a modification of a spec- 
trophotometric technique [20]. Briefly, varying 
amounts of L-a-lecithin (0-50 Ixg/ml) were added to 
test tubes containing 2ml of 0.1 M ammonium fer- 
rothiocyanate and 2 ml of chloroform. The contents 
were mixed vigorously for 1 min and centrifuged at 
6,000rpm (Safeguard Centrifuge, Clay-Adams) for 
5 min to fully separate the two phases. The aqueous 
phase was removed and the absorbance of the re- 
maining organic phase was measured at 488 nm with 
a spectrophotometer (UV/Vis Perkin-Elmer spectro- 
photometer Lamda 3) to establish a calibration curve. 
The concentrations of unknown samples were then 
determined from the calibration curve. 
2.2. CMC determination 
To determine the critical micelle concentration 
(CMC) of ionized DIP, rhodamine 6-G was mixed 
with increasing concentrations of DIP in solution at 
pH 3.0 (0.001 M HC1). The solution was excited at a 
wavelength of 480nm and observed at 550 nm in a 
Perkin-Elmer luminescence spectrophotometer LS- 
50B. The fluorescence intensity of the solution was 
plotted against concentration of ionized DIP, with 
100% intensity defined as the rhodamine 6-G inten- 
sity with no surfactant added. The inflection point of 
the curve was reported as the CMC. 
A second method to determine CMC was per- 
formed using the relationship of ionized DIP concen- 
tration and surface tension. Surface tension measure- 
ments were performed using a CRC-DuNotiy interfa- 
cial tensiometer [21]. The pH of the solution was 
adjusted to pH 3.0 in distilled H20 with hydrochloric 
acid with a constant temperature of 22°C. 
2.3. Effective release ratio (Re) and effective solubi- 
lization ratio (Se) determination 
Unilamellar liposomes (600 nm; 25 mM) contain- 
ing 100 mM calcein (> self-quenching concentration) 
were suspended in pH 4.3 acetate buffer with increas- 
ing DIP. Equilibration was allowed to occur for 
30 min at room temperature. The released calcein was 
excited at 496nm and observed at 517 nm at 22°C. 
The percentage of released calcein was calculated by 
the equation 1(%)= (I a - lb )  / (I x --lb) × I00 [22], 
where I X is the 100% fluorescence intensity value 
when adding excess Triton X-100 (10mM) and I, 
and I b are the fluorescence intensities after incuba- 
tion with and without DIP, respectively. The effective 
molar ratio (Re) of surfactant to total lipid including 
L-a-lecithin, DMPG and cholesterol was defined as 
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the point when 50% of calcein was released. During 
this process, the surfactant must come in contact with 
the lipid bilayer and partition into the hydrophobic 
environment. A substantial portion of the effect of 
most detergents causing membrane lysis has taken 
place after 30min incubation with liposomes [23]. 
Complete quilibrium between surfactants and lipids 
can take several hours [24]; however, after this time, 
detergent-induced r lease of liposomal contents could 
be masked by the concomitant spontaneous diffusion 
of solutes out of the vesicles. This fact has to be 
taken into account when using tracer molecules to 
study fusion or leakage vents. 
Turbidity measurements of a membrane prepara- 
tion as a function of added detergent were analyzed 
in terms of percent solubilization [25]. The lipid 
concentration was 180 txM and the turbidity of the 
600 nm liposome preparation was determined with a 
spectrophotometer (340 nm) in pH 4.3 acetate buffer 
at 22°C. The turbidity was plotted against he molar 
ratio of surfactant to lipid to calculate its effective 
solubilization ratio, Se (molar ratio of surfactant to 
total lipid), defined as the point at which 50% of 
lipids were solubilized. 
2.4. pH Sensitivity of DIP and its effect on calcein 
release from liposomes 
To determine the ability of DIP to cause mem- 
brane lysis/leakage, studies were conducted which 
varied either the pH or DIP concentration i  a solu- 
tion of calcein containing liposomes (described 
above). Increasing DIP concentrations (0.01-0.8 mM) 
were added into three phosphate buffer systems (pH 
5.5, 6.5, and 7.5) containing liposomes with calcein. 
The suspensions were incubated for 30 min at 22°C 
and the percentage of calcein release was calculated 
by the equation 1(%) = (I a - Ib ) / ( l  x - - /b )  X 100 as 
previously described [22]. 
2.5. Membrane lysis profile of DIP when incorpo- 
rated into liposomes 
Liposomes were prepared with calcein and differ- 
ent molar ratios of DIP. The various DIP-liposome 
preparations were incubated with phosphate buffers 
(pH 5-8) for 30 min to determine the release charac- 
teristics. The residual fluorescence of the liposomes 
at pH 8.0 was considered to be 0% and 100% release 
was set by lysing the liposomes with Triton X-100 at 
each pH [26]. 
2.6. Chemical and biological stability of DIP 
The aqueous tability of DIP was determined by 
incubating different concentrations of DIP in pH 
buffers (pH 2-8) with 5% DMSO (dimethyl sulfox- 
ide) as a co-solvent at 37°C. Periodic samples were 
removed and DIP concentration was quantified using 
an HPLC method. The HPLC system consisted of a 
Milton Roy CM 4000 pump, an LDC Analytical 3200 
absorbance detector, a Hewlett Packard 3395 integra- 
tor and a Spectra Physics SP 8780 autosampler. A 
3.9 X 75mm C8 column (Nova-Pak) along with a 
mobile phase consisting of 55% acetonitrile and 45% 
10mM pH 8.0 Na2HPO 4 solution was used to sepa- 
rate and determine intact DIP from its degradation 
products at 210nm. The flow rate was set at 
1.0ml/min. The degradation rate constants were 
plotted against pH to create the pH hydrolysis profile 
of DIP. 
To determine the hydrolysis rate of DIP in biologi- 
cal systems, a porcine esterase was used to hydrolyze 
the ester linkage. Varying concentrations of DIP in 
pH 7.0 phosphate buffer solution with 5% DMSO 
were incubated at 37°C with increasing concentra- 
tions of the esterase. Aliquots were removed at peri- 
odic intervals and DIP concentration was measured 
with HPLC as described above. Rate constants of 
DIP were calculated to predict its biodegradability. 
2.7. Cellular toxicity 
The cellular toxicity of DIP was monitored in a 
human neuroblastoma cell line, SKnSH, using the 
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide (MTT) assay [27]. Briefly, subconfiuent 
monolayered cultures were incubated in a 96-well 
plate (104 cells/well) with 2001xl of RPMI 1640 
growth medium (100U/ml  penicillin, 100txg/ml 
streptomycin and 10% fetal bovine serum) at 37°C, 
5% CO 2 and 100% humidity environment for three 
days. The growth medium was removed and DIP 
added from 100ng/ml to 10mg/ml  in 200 i~1 fresh 
growth medium. The cells were maintained for an 
additional 48h. The incubation medium was re- 
moved, cells were fed with 200 txl of fresh medium 
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at the end of the growth period and 50 Ixg of MTT 
was added to each well. The plates were wrapped 
with aluminum foil and incubated for 6h at 37°C. 
After the incubation, the medium was removed and 
the remaining MTT-formazan crystals were dissolved 
in 200 Ixl of DMSO. Glycine buffer (25 pA, pH 10.5; 
0.1 M glycine and 0.1 M NaC1) was added to all 
wells, the plates shaken for 2 min and the absorbance 
at 490rim was obtained immediately. The ID50 was 
defined as the drug concentration required to reduce 
by 50% the absorbance of the MTT-formazan crys- 
tals, indicating 50% cell death. 
2.8. Ability of DIP to facilitate cationic lipid medi- 
ated gene transfer 
Cationic-liposomes were prepared from DOTAP 
and DOPE with or without DIP. All liposomes were 
prepared by hydration of a dried lipid film with 
sterile water [12]. The liposome suspensions were 
sonicated with a probe sonicator until clear. Two 
liposome formulations were tested: DOTAP/DOPE 
(1 : 1, molar ratio) and DOTAP/DOPE/D IP  (1:1:1, 
molar ratio). The cationic lipids (15 Ixg of DOTAP) 
were mixed with 3 ixg of pDNA (pGL3, Promega) 
which had been isolated using a Megaprep Kit (Pro- 
mega). The pGL3 plasmid codes for the production 
of a truncated cytoplasmic compartmentalized lu- 
ciferase under the control of a SV40 promoter and 
enhancer. The lipid/plasmid suspension was added 
to SKnSH cells (2 × 105 cells/well) in 5001xl 
serum-free medium (RPMI 1640). After 5h, the 
medium was removed and replaced with medium 
containing 10% fetal bovine serum ( lml)  and the 
cells were incubated for an additional 24 h. The cells 
were lysed and the luciferase enzyme expression 
measured by luminescence as described [28]. Lu- 
ciferase content was corrected by total cellular pro- 
tein using a BCA (Pierce) protein assay. 
3. Results 
3.1. CMC determination of DIP 
An important parameter in characterizing surfac- 
tants is the concentration at which micelles form. All 
experiments were conducted at pH 3.0 to ensure that 
DIP was in an ionized state (> 99.9%). Rhodamine 
6-G is a fluorophore that has been shown to be useful 
in determining the CMC of cationic surfactants [29] 
such as ionized DIP. We measured the decrease of 
fluorescence intensity in an ionized DIP solution as 
the fluorophore (rhodamine 6-G) was quenched within 
micelles. As the ionized DIP concentration i creased, 
fluorescent intensity showed a sharp decrease indicat- 
ing micelle formation. 
An independent measurement of CMC using sur- 
face tension measurements of ionized DIP in aqueous 
solution corroborated the results from the fluores- 
cence studies. As DIP concentration increased, the 
surface tension of the solution sharply decreased until 
the formation of micelles occurred. From these two 
independent experiments, we determined the CMC of 
DIP to be 0.10-0.18 mM (Table 1). 
3.2. Effective release ratio (Re) and effective solubi- 
lization ratio (Se) determination of DIP 
While the CMC value is useful to describe surfac- 
tants, it does not necessarily describe how a surfac- 
tant may release materials from lipid vesicles [23,30]. 
Re describes the molar ratio of a surfactant to total 
lipid required to release the liposomal contents to the 
outer environment. The Re was determined by fitting 
a curve of calcein release from liposomes at increas- 
ing molar ratios of DIP to lipid. A computer program, 
Scientist (Micromath; Salt Lake City, Utah), was 
used to fit a curve to the data. The Re was then 
determined to be 1.0 (Fig. 1). 
Table 1 
The CMCs of different surfactants and ionized DIP determined through rhodamine 6-G or through CRC-DuNoiJy interfacial tensiometer 
Compound Literature CMC (mM) CMC through tensiometer (mM) CMC through rhodamine 6-G (mM) 
Triton X- 100 0.2-0.4 0.15-0.3 0.2-0.5 
SDS 8.2 7.5-8.5 N /A  a 
CTAB 0.7-0.92 N/A  ~ 0.6-1.0 
Ionized DIP N /A  ~ 0.1-0.18 0.1-0.25 
Not applicable. 
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Fig. 1. The ability of DIP to induce calcein release at increasing molar ratios of DIP to lipid when incubated in a pH 3.0 citrate buffer for 
30 min (n = 3). The effective release ratio was determined to be 1.04 + 0.09 (mean + SD). 
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Fig. 2. The effective solubilization ratio determined by turbidity 
analysis (n = 3). Liposomes were incubated with increasing DIP 
in a pH 3.0 citrate buffer while the optical densities (mean + SD) 
were recorded. The effective solubilization ratio (Se) was deter- 
mined to be approximately 4.0. 
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Fig. 3. The percent (mean+SD) DIP-induced calcein release 
from liposomes after 30 min in three phosphate buffer solutions: 
pH 5.5 (O), 6.5 (A), and 7.5 (×)  (n = 3). Significant differ- 
ences (p  < 0.01; ANOVA) were observed at all pH groups after 
DIP reached 0.19 mM. 
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Fig. 4. The effects of pH and DIP/l iposome ratios (R = 0 (0) ,  
0.1 (• ) ,  0.2 ( • ), and 0.4 ( × )) on DIP-induced calcein release 
(mean_+SD) from liposomes after 30min (n= 3). There were 
significant differences (p  < 0.01; ANOVA) among R = 0.1, R = 
0.2 and R = 0.4 groups. 
Se describes the concentration of a surfactant re- 
quired to solubilize a given amount of lipid. To 
determine Se, we measured the turbidity of a 
DIP/liposome suspension. Complete solubilization 
was defined as the point at which all membranes 
were transformed into mixed micelles yielding a 
transparent solution. The turbidity of the liposome 
suspension initially increased with the addition of 
DIP, indicating an interaction with liposomes causing 
the transition from bilayers to mixed micelles. Fur- 
ther addition of DIP resulted in a decrease of turbid- 
ity until complete solubilization was obtained. After 
this point, additional detergent had only a slight 
effect on the dispersion's turbidity. The Se of the 
system was determined to be approximately 4 (Fig. 
2). 
release. Calcein was released sigmoidally at pH 5.5 
as DIP concentration i creased (Fig. 3). However, 
with the lower surface active properties of DIP at pH 
7.5, calcein release was slightly increased at higher 
DIP concentration. This release was most likely due 
to saturation of the space between the lipid bilayers 
with increasing amount of DIP. Since distribution 
between the aqueous environment and lipid bilayer 
must occur for DIP to elicit membrane lysis, no 
significant differences (ANOVA) between calcein re- 
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3.3. pH Sensitivity of liposomal-calcein release by 
DIP 
To determine whether DIP becomes effective in 
acidic environments but has limited effect at extracel- 
lular biological pH, calcein-containing liposomes 
were incubated with increasing amounts of DIP at 
three pHs (5.5, 6.5, and 7.5). An increase in fluores- 
cence intensity indicates membrane lysis and calcein 
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Fig. 5. (A) The chemical degradation profile of DIP at pH 1.4 
and 37°C over time (n = 3). (B) The overall pH rate profile of 
° 
DIP at _7 C (n = 3). Data are expressed as mean+SD. 
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lease and pH were observed until 0.19raM was 
reached (p < 0.01). 
3.4. Lysis profile of DIP when incorporated into 
liposomes 
We determined the ability of unionized DIP incor- 
porated into liposomes to be protonated atlower pHs, 
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Fig. 6. (A) Biological degradation profile of 0.65 i~mole of DIP 
when incubated with 0.9U of esterase at pH 7.0 and 37°C. (B) 
The linear relationship between the degradation rate constant 
(mean + SD) of DIP and the ratio of esterase to DIP (U/p,  mole) 
at 37°C (n = 4, R 2 = 0.99), 
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Fig. 7. The effect of DIP concentration on cell (SKnSH) survival 
measured by MTT assay after 48h. The IDso of DIP was 
determined to be 1.2raM (n = 4). Data are expressed as mean_+ 
SD. 
facilitating the release of entrapped materials. Lipo- 
somes containing calcein were prepared with increas- 
ing ratios of DIP and incubated at decreasing pHs. 
Minimal calcein release was observed at the lower 
DIP/liposome molar ratio group (0.1) but at the 0.4 
ratio group calcein release increased sigmoidally (Fig. 
4). As pH decreased, calcein release increased in all 
groups. After the pH dropped to 6.0, significant 
differences (ANOVA; p <0.01) were observed 
among the ratio groups 0.4, 0.2 and 0.1. Compared to 
other groups, the system at ratio 0.4 is unstable at 
physiological pH probably due to the alternations in
lipid packing. 
3.5. Stability test and toxicity screen of DIP 
To be useful in facilitating pDNA transfer, an ideal 
surfactant must be degraded in the intercellular mi- 
lieu, thus limiting potential toxicity. DIP should be 
degraded by ester hydrolysis either chemically or 
enzymatically. The hydrolytic stability of DIP was 
assessed by incubating the compound in pH buffers 
and monitoring the concentration of the starting ma- 
terial remaining intact. Using the program Scientist to 
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difference was observed between DOTAP/DOPE and DOTAP/DOPE/DIP (p < 0.01, ANOVA). Data are expressed as mean _+ SD. 
fit the degradation curve, we were able to determine 
the pH dependent pseudo-first order degradation rate 
constants (k). DIP is at its most stable state (k = 0.055 
per day) at pH 2.8. The degradation rate constant 
reached a plateau after pH 5.9 (k = 0.70 per day) 
(Fig. 5(B)). 
To assess the enzymatic stability of DIP, we used 
porcine esterase as a model enzyme. Fig. 6(A) illus- 
trates the biological degradation of DIP when the 
ratio of DIP to esterase equals 1.4U/p~mole. By 
comparing the chemical degradation rate constant and 
biological degradation rate constant, we found that 
the biological degradation of DIP at pH 7.0 was 
approximately 32 times faster than that of DIP in 
buffer solution (1.0U/p~mole), demonstrating the 
biodegradability of DIP (Figs. 5 and 6). 
A more important parameter than biodegradability 
of DIP is cellular toxicity. A commonly used MTT 
assay was used to measure the cellular toxicity of 
DIP. The number of viable cells (measured indirectly 
by the absorbance of MTT byproduct) started to drop 
at 100 p~g/ml and stopped after 1000p~g/ml (Fig. 
7). IDso was then determined at380 ~g/ml  (1.2 mM). 
3.6. Ability of DIP to facilitate gene transfer 
A 5-fold increase in gene transfection over the 
control cationic-liposome DOTAP/DOPE was 
achieved by the incorporation of DIP into the lipid 
system, demonstrating the ability of DIP to increase 
gene transfer (Fig. 8). This experiment illustrates the 
efficacy of DIP use in the SKnSH cell line. It should 
be noted with each particular cationic lipid mixture 
and each cell line the transfection protocol must be 
optimized. In this experiment a commonly used ratio 
of cationic lipid to pDNA (1:5 w/w)  was chosen for 
the transfection protocol. Other results might be ex- 
pected with a different ransfection protocols or with 
an alternative cell line. 
4. Discussion 
Gene therapy is a promising approach for the 
treatment of a variety of disorders. While several 
approaches are available for cellular delivery of DNA, 
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the non-viral cationic-liposome approach is attractive 
due to the ease of production of liposomes, the ability 
of a non-viral system to transfect a variety of cell 
types, and the lack of immune toxicity. While non- 
viral systems are currently somewhat inefficient, they 
will undoubtedly improve with the production of new 
non-viral delivery systems and the determination of
rate limiting mechanisms which govern non-viral gene 
delivery. In this report, we investigated the escape of 
DNA from endosomes as a potential limiting step in 
cationic-liposome-mediated d livery of genes. The 
underlying objective was to evaluate the usefulness 
of an endosome disrupting compound to increase 
cytoplasmic concentrations of pDNA. 
Imidizolyl based lipids have been used success- 
fully for in vitro delivery of pDNA [31] establishing a 
rational for the use of imidazole based vectors. DIP is 
an imidazolyl based surfactant in the BPS family 
which is proposed to facilitate the transport of pDNA 
through the endosomal pathway. BPSs take advan- 
tage of the acidic environment within endosomes to 
protonate a lysosomotropic amine thus increasing its 
surface active properties. After the BPS becomes 
ionized, it can assist he destabilization of the endoso- 
mal membrane. To lessen adverse effects of the 
ionized BPS, an ester bond was introduced into DIP's 
structure making it biodegradable. DIP, has recently 
been shown to reduce the concentration of oligo- 
nucleotides required to produce a biological effect 
[ 18] using a tissue culture system. In this report, DIP 
was further characterized and evaluated for its useful- 
ness in non-viral gene delivery. 
For basic amines uch as DIP, the intrinsic ioniza- 
tion constant and the local pH environment will 
determine the percent ionized. The reported pK a of 
DIP is 6.8 [18]. When the pH drops to endosomal pH, 
approximately 6.0-5.0 [32], up to 98% of DIP can be 
ionized. In this pH range, DIP exhibits increased 
surface active properties and could presumably lyse 
the endosomal membrane before it matures into a 
lysosome. At physiological pH, unionized DIP re- 
sides within lipid bilayer. When pH declines, DIP 
will be protonated and form mixed bilayers with 
endosomal lipids. When the amount of ionized DIP 
increases, vesicles will be humpbacked with DIP at 
regions of high curvature and eventually the mixed 
micelles will be observed [33]. Throughout the transi- 
tion from lipid vesicles, mixed bilayer sheets to 
mixed micelles, pDNA may be released. If passive 
diffusion is the cellular entry pathway of DIP, the 
larger pH gradient in the lysosomes would force 
accumulation in these intracellular compartments, 
similar to the lysosomal detergent, dodecyl imida- 
zole. Lysosome rupture would then lead to severe 
toxic effects. In this report, DIP was incorporated 
into liposomes to force the compound to enter via 
endocytosis, allowing DIP to encounter the early 
endosomes before reaching the later stage lysosomes. 
The number of possible analogs of the BPS family 
are immense. In order to determine what physico- 
chemical parameters influence the biological activity 
of BPSs, we established a series of evaluation tests 
associated with surfactants. Presently, it is not clear 
which measured parameter would be useful in the 
characterization f BPS for gene delivery. The cur- 
rently established methods have been optimized for 
studying small molecule transport instead of macro- 
molecules such as pDNA. In later presentations, 
structure-activity relationships will be established us- 
ing analogs of DIP and the various parameters (CMC, 
Re, Se, etc.) will be used to correlate transfection 
efficiency. 
The first parameter determined for DIP was the 
CMC. While the CMC is a useful parameter in 
describing surfactants (i.e. hydrophilicity, surface x- 
cess), it may not be the best parameter to measure the 
ability of a surfactant o cause membrane lysis. 
Therefore, the effective Re and Se were utilized to 
describe the ability of DIP to lyse membranes. The 
lower the Se and Re, the less surfactant is required to 
lyse membranes. The amount of DIP required to 
reach Se was approximately four times higher than 
that required to reach Re which is similar to other 
surfactants [23]. For example, the Re and Se of Triton 
X-100 are 0.3 and 1.7 and the Re and Se of SDS are 
1.2 and 2.5 [23] while for DIP the values are 1.0 and 
4.0, respectively. A compound that increases the 
release rate of an entrapped compound without caus- 
ing indiscriminate membrane lysis should have re- 
duced toxicity. At present, the values of CMC, Re, 
and Se for DIP have little biological relevance. As 
other members of the BPS class are characterized 
within these parameters, it is expected that particular 
physicochemical properties will be predictive of bio- 
logical activity. 
The ability of DIP to release liposomally entrapped 
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molecules was tested as a proof of the principle 
experiment of the compound's pH sensitivity. As the 
DIP/liposome molar ratio was increased and pH 
decreased, more calcein was released from the lipo- 
some model system. Calcein release induced by DIP 
when it was incorporated into the liposome system 
was slightly higher than that caused by DIP when it 
was added to a solution containing calcein liposomes. 
The greater elease could be due to the dilution of 
DIP or may be related to partitioning barriers. This 
set of experiments demonstrated the ability of DIP to 
facilitate liposomal release of membrane ntrapped 
materials and may be indicative of events occurring 
within cellular endosomes. 
After releasing of membrane ntrapped molecules 
in a pH-sensitive manner, the biodegradability of DIP 
had to be confirmed. In the first experiments, the 
hydrolytic stability of the compound was tested over 
a range of pHs. DIP was stable to hydrolytic leavage 
at physiological pH with a degradation half life of 
27 h. The half life of DIP was 55 min in the presence 
of porcine esterase at a ratio of 1.0 U 
(esterase)/ixmole (DIP) at pH 7.0. The degradation 
rate of DIP in vivo would be expected to be greater 
due to the greater number of esterase (e.g. lipase) 
molecules which are available for DIP metabolism 
after DIP's release from the liposomal membrane. 
A major concern with the use of agents to enhance 
non-viral gene delivery is that any compound added 
to a delivery vector might contribute to the toxicity of 
the system. The toxicity of a given compound is often 
related to its stability. The biodegradability of DIP 
may decrease its cellular toxicity. In the MTT screen, 
the addition of an ester group to the surfactant re- 
sulted in a less toxic effect as compared to N-dodecyl 
imidazole, a first generation lysosomotropic detergent 
[16], by approximately 30-fold. While this study im- 
plies that ester containing imidazole based surfactants 
are less toxic than their straight chain analogs, it is 
unclear how the toxicity of DIP alone will compare 
to cationic-liposome mediated elivery. When DIP 
was incorporated into anionic liposomes, the toxicity 
was two times higher than that caused by DIP only 
(data not presented). The toxicity is most likely re- 
lated to the total amount of DIP delivered to the cell 
which is increased by the use of liposomes. 
In the final set of experiments, the inclusion of 
DIP into cationic-liposomes increased the amount of 
transgene xpressed using an in vitro tissue culture 
model. The increase in luciferase xpressed might be 
an accumulation of multiple effects of DIP acting at 
the membrane l vel through surface activity and/or 
serving as a pro-fusogen. The ability of DIP to 
increase cell transfection has also been demonstrated 
in primary rat glial cells and transformed human 
embryonal kidney cells. DIP also has been shown to 
be effective when used with DOSPA cationic lipid 
gene delivery systems (data not shown). Interestingly, 
when DOTAP/DIP (1:1) lipid particles were made, 
they were as effective in gene transfection as 
DOTAP/DOPE liposomes. This feature implies that 
DIP bears fusogenic properties within the cell. It 
should be pointed out that the increase in endosomal 
release of pDNA is not the only mechanism which 
could lead to increased transfection. Other explana- 
tions include the possibility that DIP may increase 
either the association of pDNA with cationic lipid 
complexes or increase the amount of total lipid-DNA 
complex which is transported within the cell. Future 
studies will delineate the mechanism of increased 
transgene xpression. While only preliminary experi- 
ments have been conducted with DIP containing 
cationic-liposomes, these early results appear promis- 
ing and additional studies are required to understand 
usefulness in non-viral gene delivery. 
The inclusion of pH-sensitive surfactants within 
non-viral ipid delivery system is another method for 
increasing transgene xpression. It is assumed that 
the increased efficacy is due to greater transfer of 
pDNA from the endosome to the cytosol. In this 
report, we present a starting point to understand the 
role of DIP in membrane fusion and gene delivery. 
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